NDC 73070-503

Insulin Degludec

Insulin Degludec

Insulin Degludec is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk Pharma, Inc.. The primary component is Insulin Degludec.

Product ID73070-503_c1be283d-4b1d-4996-b2a7-4488dbff3037
NDC73070-503
Product TypeHuman Prescription Drug
Proprietary NameInsulin Degludec
Generic NameInsulin Degludec
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2022-07-01
Marketing CategoryBLA /
Application NumberBLA203314
Labeler NameNovo Nordisk Pharma, Inc.
Substance NameINSULIN DEGLUDEC
Active Ingredient Strength200 U/mL
Pharm ClassesInsulin Analog [EPC], Insulin [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 73070-503-15

3 SYRINGE, PLASTIC in 1 CARTON (73070-503-15) > 3 mL in 1 SYRINGE, PLASTIC
Marketing Start Date2022-07-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Insulin Degludec" or generic name "Insulin Degludec"

NDCBrand NameGeneric Name
73070-400Insulin Degludecinsulin degludec
73070-403Insulin Degludecinsulin degludec
73070-503Insulin Degludecinsulin degludec
0169-2550Tresibainsulin degludec
0169-2660Tresibainsulin degludec
0169-2662Tresibainsulin degludec
50090-3491Tresibainsulin degludec

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.